Moderna's Covid-19 vaccine may be ready for use by December

  • Moderna's Covid-19 vaccine may be ready for use by December

Moderna's Covid-19 vaccine may be ready for use by December

If the results are positive, the federal government can approve the vaccine for emergency use.

The first interim analysis of the vaccine's efficacy will happen when 53 people in the entire study show symptoms of COVID-19, the report said. Moderna would then reportedly conduct a second analysis when 106 people get sick with the coronavirus.

Also this week, Pfizer's CEO Albert Bourla revealed a similar timeline for its BioNTech-partnered COVID-19 vaccine, saying that the company could seek an EUA in the U.S. in the third week of November. In addition to Pfizer, it has struck deals on supplies with AstraZeneca Plc and other overseas makers of vaccine candidates.

The CEO of Cambridge-based biotech company Moderna said their vaccine could be given emergency authorization as early as December. "If one ingredient is missing, we can not make the vaccine", the Journal quoted him as saying.

The Canadian government has pledged to order up to 20 million doses of Moderna's mRNA-1273, once it is approved; that vaccine supply will be sourced from Moderna's European production capacity with its strategic manufacturing partner Lonza of Switzerland, and ROVI of Spain for fill-finish services.

Previously, Bancel told the Financial Times that Moderna's vaccine candidate would be ready for EUA submission on 25 November.

Drugmakers are racing to develop a COVID-19 vaccine, with more than 150 potential therapies being developed and tested globally. The US Food and Drug Administration could decide whether to gr ant an emergency use authorization for the shot in December if Moderna submits an application soon after reaching that safety milestone, according to the Journal.

Bancel's comments suggest Moderna's timetable is not far off Pfizer's, which said last week it expects to seek U.S. authorisation of emergency use of its vaccine by late November.